Understanding COVID-19 Infections in Pregnant Women and Their Babies in 5 African Nations (periCOVID Africa)
NCT ID: NCT05409274
Last Updated: 2023-11-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
6635 participants
OBSERVATIONAL
2020-11-01
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Estimate the seroepidemiology of COVID-19 infection among pregnant women in these countries
Define the immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in pregnant women and their babies and determine the presence of antibodies in cord blood
Work with communities to develop understanding of infection prevention and control techniques to reduce the spread of COVID-19 amongst the pregnant population
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessing the Impact of Group Antenatal Care on IPTp Uptake in Tanzania
NCT04148690
A New Approach to Deliver Malaria Preventions to Pregnant Women at a Community Level in Uganda
NCT00118027
MiMBa Pregnancy Registry
NCT04825782
Malaria Burden in Pregnant Women and the Incidence of Pregnancy in a Cohort of Nulligravida
NCT06162078
Sulphadoxine-Pyrimethamine for Intermittent Preventive Treatment of Malaria in Pregnancy in Uganda
NCT01184911
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Data from this study will be pooled from 5 countries; Malawi, Uganda, Mozambique, the Gambia, and Kenya to provide robust and generalisable evidence from the different regions in sub-Saharan Africa. the investigators hope that with this information, they can contribute to the evidence base for recommendations, guidance and policy decisions for the clinical management and public health response to protect pregnant women and their infants.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pregnant women
Pregnant women enrolled across 5 country study sites at any point during pregnancy, up to and including the day of delivery.
No Intervention
No Intervention
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No Intervention
No Intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Exclusion Criteria
14 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
London School of Hygiene and Tropical Medicine
OTHER
Fundação Manhiça
OTHER
Aga Khan University
OTHER
MU-JHU CARE
OTHER
University of Liverpool
OTHER
King's College London
OTHER
Makerere University
OTHER
University of Bergen
OTHER
University of Malawi
OTHER
St George's, University of London
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kirsty Le Doare
Role: PRINCIPAL_INVESTIGATOR
St George's, University of London
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Aga Khan University
Nairobi, , Kenya
University of Malawi
Zomba, , Malawi
Fundação Manhiça
Manhiça, , Mozambique
MRC Unit The Gambia at LSHTM
Fajara, , The Gambia
MRC/UVRI
Entebbe, , Uganda
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
13487-10
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.